Investigators
Global Reach
Contact
General Inquiries
Investors Contact
Investigators Contact
ja
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Services
Service Sub Menu
Therapeutic Expertise
Expertise Sub Menu
About
Linical at a Glance
Company News & Events
Leadership
Global Reach
History
Management Philosophy
Sustainability
Resource Center
Articles & Research
Case Studies
White Papers & Reports
Careers
Investors
Investor Sub Menu
Request a Proposal
EXPLORE ALL
Drug Development Strategy
Protocol Development & Study Design
Regulatory Consulting
Regulatory Affairs
Quality Assurance
Medical Writing
EXPLORE ALL
Clinical Trial Management
Feasibility & Study Start Up
Project Management
Medical Affairs & Pharmacovigilance
Clinical Monitoring
Patient Recruitment
Biometrics
Training Academy
Functional Services Provider
Coming Soon
Request a Proposal
Global Reach
Investigators
Drug Development Strategy
Protocol Development & Study Design
Regulatory Consulting
Regulatory Affairs
Quality Assurance
Medical Writing
Clinical Trial Management
Feasibility & Study Start Up
Project Management
Medical Affairs & Pharmacovigilance
Clinical Monitoring
Patient Recruitment
Biometrics
Training Academy
By Focus Area
Oncology
Endocrinology & Metabolic
Neurology & Psychiatry
Other Focus Areas
Immunology & Vaccine
By Phase
Early Phase Studies
Phase II-III Studies
Late Phase Studies
Management
A Message from our CEO
Board of Directors
Growth Strategy
Investors Contact
Financial Information
Earnings Highlights
Financial Position
Cash Flow
IR Library
Earnings Statement
Earnings Presentation
Other Materials
Stock Information
Shareholders’ Meeting
Stock Information
Dividends
IR News
IR Calendar
Stock Quotes
FAQs
Disclaimer
LINICAL
White Papers
Industry News
All
CRO
Asia-Pacific
Corporate
Regulatory
Patient Journey
Sustainability
Technology
Awards
Industry News
Neurology
THE LATEST
June 3, 2026
CRO
PharmaBoardroom Interview with Dr Toshiaki Nagafuji on the Japanese Clinical Development Landscape in 2026
"Mid-sized CROs like Linical can be suitable partners for relatively small pharmaceutical and biotech companies that are searching for flexibility...
Continue Reading
SIGN UP FOR OUR NEWSLETTER
Posts about Industry News
June 3, 2026
CRO
PharmaBoardroom Interview with Dr Toshiaki Nagafuji on the Japanese Clinical Development Landscape in 2026
Continue Reading
SIGN UP FOR OUR NEWSLETTER
.jpg)